3-methylcrotonyl-CoA carboxylase 1 deficiency: genes and variants
Explore variant evidence for 3-methylcrotonyl-CoA carboxylase 1 deficiency across 1 analyzed protein (MCCC1). Linked ClinVar records include 21 pathogenic or likely pathogenic variants, 189 variants of uncertain significance and 21 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to 3-methylcrotonyl-CoA carboxylase 1 deficiency
MCCC1: Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial
It provides one subunit of mitochondrial methylcrotonyl-CoA carboxylase, an enzyme required for leucine degradation. Biallelic loss-of-function variants cause 3-methylcrotonyl-CoA carboxylase deficiency, with clinical severity ranging from asymptomatic biochemical abnormalities to metabolic decompensation.
21 ClinVar pathogenic / likely pathogenic and 210 uncertain variants in MCCC1 have source records linked to 3-methylcrotonyl-CoA carboxylase 1 deficiency. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to 3-methylcrotonyl-CoA carboxylase 1 deficiency
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| MCCC1 G180V | 180 | ATP-grasp | Pathogenic / likely pathogenic (★★) |
| MCCC1 A289V | 289 | ATP-grasp | Pathogenic / likely pathogenic (★★) |
| MCCC1 T465I | 465 | Biotin carboxylation | Pathogenic / likely pathogenic (★★) |
| MCCC1 R66C | 66 | Biotin carboxylation | Pathogenic / likely pathogenic (★★) |
| MCCC1 E288G | 288 | ATP-grasp | Pathogenic / likely pathogenic (★★) |
| MCCC1 I434M | 434 | Biotin carboxylation | Pathogenic / likely pathogenic (★★) |
| MCCC1 R444H | 444 | Biotin carboxylation | Pathogenic / likely pathogenic (★★) |
| MCCC1 R421W | 421 | Biotin carboxylation | Pathogenic / likely pathogenic (★★) |
| MCCC1 M1V | 1 | Pathogenic / likely pathogenic (★★) | |
| MCCC1 C276R | 276 | ATP-grasp | Pathogenic / likely pathogenic (★) |
| MCCC1 R385G | 385 | Biotin carboxylation | Pathogenic / likely pathogenic (★) |
| MCCC1 A435T | 435 | Biotin carboxylation | Pathogenic / likely pathogenic (★) |
| MCCC1 L437P | 437 | Biotin carboxylation | Pathogenic / likely pathogenic (★) |
| MCCC1 E366K | 366 | Biotin carboxylation | Pathogenic / likely pathogenic (★) |
| MCCC1 M1T | 1 | Pathogenic / likely pathogenic (★) | |
| MCCC1 S535F | 535 | Pathogenic / likely pathogenic (★) | |
| MCCC1 E59G | 59 | Biotin carboxylation | Pathogenic / likely pathogenic (★) |
| MCCC1 P152L | 152 | Biotin carboxylation | Pathogenic / likely pathogenic (★) |
| MCCC1 Y430C | 430 | Biotin carboxylation | Pathogenic / likely pathogenic (★) |
| MCCC1 I460M | 460 | Biotin carboxylation | Pathogenic / likely pathogenic |
| MCCC1 D532H | 532 | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in 3-methylcrotonyl-CoA carboxylase 1 deficiency
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| MCCC1 R444C | 444 | Biotin carboxylation | Conflicting reports (★) | +7: in a 3D region that tolerates change poorly (3R); R444H at the same position is pathogenic; seen in 8.2e-06 of gnomAD DNA copies; REVEL 0.904 |
| MCCC1 C276G | 276 | ATP-grasp | Uncertain (★) | +7: in a 3D region that tolerates change poorly (3R); C276R at the same position is pathogenic; seen in 1.4e-06 of gnomAD DNA copies; REVEL 0.982 |
| MCCC1 R66H | 66 | Biotin carboxylation | Uncertain (★) | +7: in a 3D region that tolerates change poorly (1R); R66C at the same position is pathogenic; seen in 6.8e-06 of gnomAD DNA copies; REVEL 0.827 |
| MCCC1 A435V | 435 | Biotin carboxylation | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; A435T at the same position is pathogenic; REVEL 0.918 |
Which prediction tools work for 3-methylcrotonyl-CoA carboxylase 1 deficiency
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 97 out of 100
- SIFT: 95 out of 100
- MutPred: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 93 out of 100
- CATVariant: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaGenome (regulatory): 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 87 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 85 out of 100
- MetaSVM: 85 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 74 out of 100
- Pangolin: 68 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 55 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaGenome (splicing): 53 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Diseases related to 3-methylcrotonyl-CoA carboxylase 1 deficiency
- 3-methylcrotonyl-CoA carboxylase deficiency, also linked to MCCC1
Frequently asked questions
Which genes have records linked to 3-methylcrotonyl-CoA carboxylase 1 deficiency?
This view contains 1 analyzed proteins: MCCC1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 21 pathogenic or likely pathogenic variants, 189 variants of uncertain significance and 21 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 4 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 240 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center